Travere Therapeutics, Inc.

TVTX · Healthcare

$65.71

Capitalización: 6.19B USDRendimiento por dividendo: —
Advance¿Es buen momento para comprar Travere Therapeutics, Inc.? Pregunta a Copenvest AIObtén una lectura Advance con IA sobre timing, riesgo y qué hacen los inversores rastreados.Preguntar a Copenvest AI

Cargando gráfico…

Noticias

Últimos titulares de esta acción

Insider Monkey4 sept 2026, 10:44

Ligand Pharmaceuticals (LGND): Massive XOMA Acquisition Doubles The Royalty Book

Investor's Business Daily24 ago 2026, 16:56

TGTX Stock Outperforms 95% of Stocks. Here's Why.

Investor's Business Daily21 ago 2026, 17:09

IBD Stock Of The Day, Travere Therapeutics, Tests Another Breakout. Can The Stock Get Any 'Sweeter?'

Investor's Business Daily21 ago 2026, 16:09

Three Biotech Stocks Stick Out With Their Stellar Charts

MarketBeat18 ago 2026, 10:01

Travere Therapeutics Sees FILSPARI FSGS Launch Top Expectations, Expands Renal Pipeline